Diabetes prevalence underestimated in Australia: Study Researchers have suggested the number of people living with diabetes could be more than a third higher than officially registered.
What’s in the 2025–26 Federal Budget for GPs? The RACGP has welcomed GP workforce incentives but said while ‘it’s clear general practice is central in this year’s Budget’, there are still missed opportunities.
‘Not for sale’: Australia defends PBS against US big pharma GPs welcome plans to make PBS-listed medicines even cheaper, but it comes as US pharma giants take aim at the scheme.
Prescriber reminder over oral contraceptive PBS changes Yaz and Yasmin are now available on the PBS – but existing patients will need a new prescription to access the lower price.
Changes in the works for general practice accreditation GPs are being encouraged to give their feedback on proposed changes to the National General Practice Accreditation Scheme.
What to expect from incoming menopause health checks A new Medicare rebate is on the way, but what is a menopause health assessment and how will it improve the care women receive?
What does the $573m women’s health package mean for GPs? Labor’s plan, matched by the Coalition, includes new PBS listings for contraceptive pills and MHT, new rebates, funded training, and bolstered Medicare payments for IUD insertions.
‘Life-changing’ eczema drug to stay on PBS Dupixent was at high risk of coming off the PBS as soon as this month due to high demand, but negotiations have secured its continued listing.
Endometriosis drug Visanne added to PBS Doctors have described dienogest as ‘miraculous’, with its listing expected to positively impact up to 500,000 patients.
‘Unprecedented’ demand on PBAC forces extra meeting Its capacity has been exceeded by a ‘huge pipeline of new medicines’, after companies put forward a record number of submissions.